Molecule Structure

Scientific Name

Cefoxitin

Description of the Drug

Cefoxitin is a semi-synthetic, broad-spectrum antibiotic for parenteral administration used for the treatment of serious bacterial infections, such as urinary tract infection, blood infection, bone and joint infection, and lower respiratory tract infection.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01331

Brand Name(s)

Cenomycin, Mefoxin, Mefoxitin

Company Owner(s)

Samson Medical Technologies Llc, Fresenius Kabi Usa Llc, Hospira Inc, Hikma Farmaceutica (Portugal) Sa, Merck And Co Inc, B Braun Medical Inc, Acs Dobfar Spa, Hikma Pharmaceuticals Usa Inc, Mylan Institutional Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Bacterial penicillin-binding protein PROTEIN FAMILY INHIBITOR CHEMBL2354204

Unichem Links

SureChEMBL SCHEMBL15971
PharmGKB PA448856
Human Metabolome Database HMDB0015426
DrugBank DB01331
PubChem: Thomson Pharma 14929780 15501432
PubChem 441199
LINCS LSM-5786
Nikkaji J17.441F
PDBe CFX
BindingDB 50335563
EPA CompTox Dashboard DTXSID1022764
DrugCentral 550
Brenda 879
ChemicalBook CB9490581
Guide to Pharmacology 10937
rxnorm MEFOXIN CEFOXITIN SODIUM CEFOXITIN
PubChem: Drugs of the Future 12012592
KEGG Ligand C06887
ChEBI 209807
ZINC ZINC000003830449